Big Money for Little Biotechs
He represents a state 3,000 miles away, but it is safe to say that U.S. Sen. Benjamin Cardin has a constituency in San Diego. At a Senate hearing today Cardin said he would fight for more funding for small biotechs, according to this story in the Baltimore Business Journal.
Specifically, Cardin wants 2.5 percent -- or $229 million -- of the $10.4 billion that the National Institutes of Health will get as part of the stimulus package to go to early-stage life science companies.
That is no doubt a popular proposal in San Diego, which is home to about 700 life science companies, most of which are small businesses.
0 Comments so far on this story...
Reader feedback
- Users may post more than one comment, but should not pose as multiple users. Multiple posts from the same IP address but with a different user name on each will be reviewed to determine whether abuse has occurred.
- Posts with overly personal attacks or unsubstantiated allegations may be edited or deleted.
- Please be patient with the posts -- there may be a delay before they appear on the site -- and make sure to enter the code in the "image verification" box.
|